Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.47
-0.02 (-0.31%)
May 2, 2025, 4:00 PM EDT - Market closed
Kura Oncology Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$23.89
Upside
+269.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $32 → $11 | Buy | Maintains | $32 → $11 | +70.02% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +332.77% | Apr 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +518.24% | Apr 28, 2025 |
| UBS | UBS | Strong Buy Maintains $27 → $14 | Strong Buy | Maintains | $27 → $14 | +116.38% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +518.24% | Feb 27, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +332.77% | Feb 6, 2025 |
| Wedbush | Wedbush | Buy Maintains $34 → $36 | Buy | Maintains | $34 → $36 | +456.41% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $37 → $40 | Strong Buy | Maintains | $37 → $40 | +518.24% | Feb 6, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | +54.56% | Jan 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 26, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $36 → $29 | Strong Buy | Maintains | $36 → $29 | +348.22% | Nov 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Nov 21, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $32 → $28 | Strong Buy | Maintains | $32 → $28 | +332.77% | Nov 21, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $37 | Strong Buy | Maintains | $32 → $37 | +471.87% | Nov 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.